7MM Corneal Edema Epidemiology Forecast 2020-2034: Increasing Prevalence and Future ...
The "Corneal Edema - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.A comprehensive report has been released providing valuable insights into the diagnosis, ...
Healio2 天
AI playing larger role in cataract surgery
AI has quietly revolutionized the field of ophthalmology.While the concept of AI may evoke futuristic images of robots and ...
Aurion Biotech Appoints Donald Munoz as Chief Financial Officer
Aurion Biotech, Inc. (Aurion), whose mission is to restore vision to millions of patients with life-changing regenerative ...
ophthalmologytimes5 天
New miniature telescope for AMD shows promise, raises postoperative concerns
Patients commonly reported unexplained blurred or hazy vision postoperatively that requires further investigation ...
Aurion Biotech Pursues IPO For Cornea Disease Treatments
Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...
PR Newswire7 天
EyeYon Medical Expands into China with New Subsidiary
EyeYon Medical is revolutionizing eye care with EndoArt®, the world's first synthetic corneal implant for chronic edema. A ...
The American Journal of Managed Care21 天
Decreased Levels of CGRP, SP Associated With Dry Eye Disease
Negative correlation between CGRP levels and corneal fluorescein staining scores was observed. Positive correlations were found between CGRP, SP levels, and noninvasive breakup times ...
ophthalmologytimes26 天
Ocugen doses first patient in phase 1 trial of OCU200 for treatment of diabetic macular edema
Ocugen announced the first patient in its OCU200 phase 1 clinical trial for diabetic macular edema (DME) has been dosed. The company describes OCU200 as a “recombinant fusion protein that consists of ...